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Introduction 
Chemical treatment with ozone (O3) is one of the most promising technologies for removal of 
organic micro-pollutants1 from wastewater effluents. Another capable treatment is chlorine dioxide 
(ClO2)2 which may be implemented in our wastewater treatment plants (WWTPs) in order to 
increase the removal of micro-pollutants from the effluent. By decreasing the content of micro-
pollutants e.g. pharmaceuticals etc. the risk of causing biological damage in the receiving waters 
will be reduced. By oxidation the micro-pollutants will be either completely mineralized, or 
transformed into structures that hopefully are easier to degrade biologically. Though, there is also a 
risk that they are transformed into structures that are similar to the parent compound and still 
biologically active or that they gain a new toxic potential. This risk increases with lowering the 
doses of oxidants. It has been shown that transformation products generated from Carbamazepine 
during chemical treatment with oxidation was more harmful to aquatic organisms compared to the 
parent compound3. To aim at complete mineralization by implementing chemical treatment with 
oxidation will increase the costs and is therefore not justified. Thus transformation products will 
most likely be formed. Another risk is formation of by-products e.g. bromate4. The aim with this 
work is to evaluate the risk for increasing the environmental hazard by formation of transformation 
products and by-products with unwanted biological effects during chemical polishing of 
wastewater. Presented here is the design and procedure of the tests which will elucidate the 
hazardous effects caused by chemical treatment of pharmaceuticals and wastewater. 
 
Material and Method 
In order to evaluate the risk of formation of hazardous compounds when water spiked with 
pharmaceuticals and wastewater is treated with chemical oxidation, ecotoxicological evaluation is 
required. The ecotoxicological tests employed were an acute toxicity test with Daphnia magna (24 
h exposure; OECD TG 210) and a growth inhibition test with microalgae (72 h exposure; OECD TG 
201). 
Experimental set-up: Purified organic free water spiked with a mixture containing 114 
pharmaceuticals and wastewater effluent collected from a wastewater treatment plant in 
Stockholm, Sweden was treated with oxidants. The starting concentration of the pharmaceutical 
mix was set to 96µg/L in order to fit the chosen ecotoxicological test. The samples were prepared 
in blue cap bottles to which different volumes of ClO2 or O3 was added according to Table 1. The 
ClO2 stock solution was prepared by mixing solutions of chlorite (ClO2-) with hydrochloric acid.The 
ozone stock solution was created by passing ozone gas from an oxygen feed reactor through 
demineralised water placed in an ice bath. The experimental set-up for the ozonation includes an 
ozone generator from ADD that operates with max 1.5 bar O2 (g). The addition of either ClO2 or O3 
to the spiked water was performed in mole ratios to the sum of mole of pharmaceuticals (Tab. 1). 
Expert judgment was used to determine the amount of the oxidants that would be added to the 
wastewater for removing pharmaceuticals from effluents. After addition of the oxidant the bottles 
were left to react for 1 h before residual oxidants was destroyed with Na2SO3 (50 mg/L) thereafter 
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were the ecotoxicological tests started. Furthermore were the oxidations of wastewater repeated 
without termination with Na2SO3 before the ecotoxicological tests (Tab. 1). This was done in order 
to elucidate at which concentration the oxidant residual becomes toxic in wastewater. 
Table 1. Samples performed with the presented mole of the oxidant in relation to 1 mole of the sum of 
pharmaceutical. 
 ClO2 or O3 
with 
Na2SO3 (50 mg/L) 
ClO2 or O3  
without  
Na2SO3 
Spiked water 
Mole ratio 
0, 0.5, 1, 2, 5 - 
Wastewater 
Conc. (mg/L) 
0, 2, 4, 6, 15 2,4,6 
 
Analysis: TOC, COD and pH was measured employing standard methods in the effluent. The 
concentration of the stock solution of ClO2 was analyzed by oxidation of DPD (N, N-diethyl-p-
phenylenediamine) using an Allcon spectrophotometer (Alldos, GmbH). The delivered ozone doses 
are measured with the indigo method5, by preparing bottles with indigo trisulfonate solution in 
demineralised water in parallel with the treatment samples. The ozone was measured by the 
unimolecular reaction between ozone and indigo which removes the strong blue colour at 600 nm. 
The pharmaceuticals were quantified by solid phase extraction (SPE) followed by liquid 
chromatography-mass spectrometry (LC-MS) with limit of detection in the order 1-10 ng/L. 
 
Results and Discussion 
The experiment will be carried out during November and December 2010. The outcome of these 
experiments will give valuable information regarding the formation of transformation products and 
by-products hazardous effect as a consequence of chemical treatment. Whether there is a 
difference in toxicity between treatment with ClO2 and O3 might be answered though this study. 
Furthermore as the oxidants is added in mole ratios of the mole sum of pharmaceuticals in purified 
organic water it will be possible to identify at which level of oxidant the most hazardous effects are 
generated. 
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